JaySumanRavalMD
Pathology • Los Ranchos, NMBlood Banking & Transfusion Medicine
Professor, Vice Chair for Clinical Affairs, and Director of Transfusion Medicine and Therapeutic Pathology, Department of Pathology, University of New Mexico
Dr. Raval is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5801 Tinnin Rd NW
Los Ranchos, NM 87107Phone+1 919-618-3621
Summary
- Dr. Jay Raval is a pathologist in Albuquerque, NM and is Director of Transfusion Medicine and
Therapeutic Pathology at the University of New Mexico. He received his medical degree from University of North Carolina at Chapel Hill School of Medicine, received post-graduate training at the University of Pittsburgh Medical Center (UPMC), and has been in practice for 11 years. He specializes in blood banking, transfusion medicine, apheresis medicine, and cellular therapies.
Education & Training
UPMC Medical Education/Institute for Transfusion MedicineFellowship, Blood Banking/Transfusion Medicine, 2010 - 2011- UPMC Medical EducationResidency, Pathology-Anatomic and Clinical, 2007 - 2010
- UPMC Medical Education (Pittsburgh)Residency, Surgery, 2006 - 2007
University of North Carolina at Chapel Hill School of MedicineClass of 2006
Certifications & Licensure
VT State Medical License 2024 - 2026
NM State Medical License 2018 - 2025
NC State Medical License 2012 - 2020
PA State Medical License 2009 - 2012- American Board of Pathology Pathology - Clinical
- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- 17 citationsDynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study.Xianming Zhu, Kelly A Gebo, Alison G Abraham, Feben Habtehyimer, Eshan U Patel
The Lancet. Microbe. 2023-09-01 - 63 citationsRed Blood Cell Transfusion: 2023 AABB International Guidelines.Jeffrey L Carson, Simon J Stanworth, Gordon Guyatt, Stacey Valentine, Jane Dennis
JAMA. 2023-11-21 - 28 citationsPlatelet Transfusion in Critical Care and Surgery: Evidence-Based Review of Contemporary Practice and Future Directions.Eric W. Etchill, Sara P. Myers, Jay S. Raval, Adnan Hassoune, Anirban SenGupta
Shock. 2017-05-01
Journal Articles
- ADAMTS13: Origins, Applications, and ProspectsBrian S Zuckerbraun, Matthew D Neal, Jay S Raval, Mitchell R Dyer, Transfusion
Abstracts/Posters
- African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic PurpuraJay S Raval, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Prolonged Circulation of Ultra-Large Von Willebrand Factor and a Reduction in ADAMTS13 Activity Promotes Microvascular Disease Following Traumatic InjuryJay S Raval, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian PopulationsJay S Raval, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
